Mark Mallon - 06 Dec 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Executive Officer, Director
Signature
/s/ Mark W. Mallon
Issuer symbol
NEO
Transactions as of
06 Dec 2021
Net transactions value
+$520,710
Form type
4
Filing time
06 Dec 2021, 15:16:42 UTC
Next filing
30 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Purchase $520,710 +17,000 +31% $30.63 72,736 06 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 151,016 06 Dec 2021 Common Stock 151,016 $49.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.